Литература
1. Food and Nutrition Board, Institute of Medicine. Dietary fats: total fat and fatty acids. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids . Washington, DC : National Academies Press, 2002. P. 422-541.
2. Тютюнник В.Л., Кан Н.Е., Ломова Н.А., Климанцев И.В. Вклад Омега-3 в микронутриентную поддержку в период беременности // РМЖ. Мать и дитя. 2017. № 15. С. 1087-1091.
3. Ших Е.В., Махова А.А. Эндемичность территории по дефициту микронутриентов как критерий формирования состава базового витаминно-минерального комплекса для перикон-цепционального периода // Акуш. и гин. 2018. № 10. С. 25-32.
4. Caron J.P., Gandy J.C., Brown J.L., Sordillo L.M. Omega-3 fatty acids and docosahexaenoic acid oxymetabolites modulate the inflammatory response of equine recombinant interleukin 1p-stimulated equine synoviocytes // Prostaglandins Other Lipid Mediat. 2019. Vol. 142. P. 1-8. doi: 10.1016/j.prostaglandins. 2019.02.007
5. Гаврисюк В.К. Применение омега-3 полиненасыщенных жирных кислот в медицине // Укр. пульмон. журн. 2001. № 3. С. 5-10.
6. Stark K.D., Van Elswyk M.E., Higgins M.R.,Weatherford C.A., Salem N. Jr. Global survey of the omega-3 fatty acids, docosahexaenoic acid and eicosapentaenoic acid in the blood stream of healthy adults // Progr. Lipid Res. 2016. Vol. 63. P. 132-152.
7. Рацион питания населения. 2013 : статистический сборник / Росстат. М. : Статистика России, 2016. 220 с.
8. Calder P.C. Docosahexaenoic acid // Ann. Nutr. Metab. 2016. Vol. 69, suppl. 1. P. 7-21. Epub 2016 Nov 15.
9. Carlson S.J., O’Loughlin A.A., Anez-Bustillos L. et al. A diet with docosahexaenoic and arachidonic acids as the sole source ofpolyunsaturated fatty acids is sufficient to support visual, cognitive, motor, and social development in mice // Front. Neurosci. 2019. Vol. 13. P. 72. doi: 10.3389/fnins.2019.00072
10. Jeffrey B.G., Weisingerb H.S., Neuringer M., Mitcheli D.C. The role of docosahexaenoic acid in retinal function // Lipids. 2001. Vol. 36, N 9. P. 859-871.
11. SanGiovanni J.P., Chew E.Y. The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina // Prog. Retin. Eye Res. 2005. Vol. 24, N 1. P. 87-138.
12. Dyall S.C. Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA // Front. Aging Neurosci. 2015. Vol. 7. P. 52. doi: 10.3389/fnagi.2015.00052
13. Zemdegs J., Rainer Q., Grossmann C.P. et al. Anxiolytic- and antidepressant-like effects of fish oil-enriched diet in brain-derived neurotrophic factor deficient mice // Front. Neurosci. 2018. Vol. 12. P. 974. doi: 10.3389/fnins.2018.00974
14. Martins B.P., Bandarra N.M., Figueiredo-Braga M. The role of marine omega-3 in human neurodevelopment, including Autism Spectrum Disorders and Attention-Deficit/Hyperactivity Disorder -a review // Crit. Rev. Food Sci. Nutr. 2019 Mar 18. P. 1-16. doi: 10.1080/10408398.2019.1573800
15. Ishihara T., Yoshida M., Arita M. Omega-3 fatty acid-derived mediators that control inflammation and tissue homeostasis // Int. Immunol. 2019. pii: dxz001. doi: 10.1093/intimm/dxz001
16. Davidson M.H. Omega-3 fatty acids: new insights into the pharmacology and biology of docosahexaenoic acid, docosapentae-noic acid, and eicosapentaenoic acid // Curr. Opin. Lipidol. 2013. Vol. 24, N 6. P. 467-474.
17. Jump D.B., Tripathy S., Depner C.M. Fatty acid-regulated transcription factors in the liver // Annu. Rev. Nutr. 2013. Vol. 33. P. 249-269.
18. Cho H.P., Nakamura M., Clarke S.D. Cloning, expression, and fatty acid regulation of the human delta-5 desaturase // J. Biol. Chem. 1999. Vol. 274, N 52. P. 37 335-37 339.
19. Burdge G.C., Wootton S.A. Conversion of a-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women // Br. J. Nutr. 2002. Vol. 88, N 4. P. 411-420.
20. Burdge G.C., Jones A.E., Wootton S.A. Eicosapentaenoic and docosa-pentaenoic acids are the principal products of a-linolenic acid metabolism in young men // Br. J. Nutr. 2002. Vol. 88, N 4. P. 355-364.
21. Conquer J.A., Holub B.J. Dietary docosahexaenoic acid as a source of eicosapentaenoic acid in vegetarians and omnivores // Lipids. 1997. Vol. 32, N 3. P. 341-345.
22. Flock M.R., Harris W.S., Kris-Etherton P.M. Long-chain omega-3 fatty acids: time to establish a dietary reference intake // Nutr. Rev. 2013. Vol. 71, N 10. P. 692-707.
23. Громова О.А., Торшин И.Ю., Егорова Е.Ю. Омега-3 полиненасыщенные жирные кислоты и когнитивное развитие детей // Вопр. соврем. педиатрии. 2011. Т. 10, № 1. С. 44-49.
24. Макарова С.Г., Вишнева Е.А. Современные представления о влиянии длинноцепочечных полиненасыщенных жирных кислот на развитие нервной системы у детей // Вопр. соврем. педиатрии. 2015. Т. 14, № 1. С. 55-56.
25. Ulven S.M., Kirkhus B., Lamglait A. et al. Metabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteers // Lipids. 2011. Vol. 46, N 1. P. 37-46.
26. Hendler S.S., Rorvik D.R. (eds). PDR for Nutritional Supplements. Montvale : Medical Economics Company, 2001. 797 p.
27. URL: http://www.mstu.edu.ru/science/actions/conferences/files/ecol2015-10.pdf
28. URL: http://www.vniro.ru/files/publish/boeva_tehnologia_jirov.pdf
29. Kirpal S. Sidhu Health benefits and potential risks related to consumption of fish or fish oil // Regul. Toxicol. Pharmacol. 2003. Vol. 38. P. 336-344.
30. Васьковский В.Е., Горбач Т.Ф., Есипов А.В. Препараты омега-3 жирных кислот и их применение в медицине // Тихоокеанский мед. журн. 2010. № 2. С. 15-19.
31. Макарова С.Г., Вишнева Е.А. Длинноцепочечные полиненасыщенные жирные кислоты классов -3 и -6 как эссен-циальный нутриент в разные периоды детства // Педиатр. фармакол. 2013. Т. 10, № 4. С. 80-88.
32. Burdge G.C., Calder P.C. Conversion of a-linolenic acid to longer-chain polyunsaturated fatty acids in human adult // Reprod. Nutr. Dev. 2005. Vol. 45. P. 581-597.
33. Pilz S., Zittermann A., Trummer C. et al. Vitamin D testing and treatment: a narrative review of current evidence // Endocr. Connect. 2019. Vol. 8, N 2. P. R27-R43.
34. Ших Е.В., Махова А.А. Витамины в клинической практике / под ред. В.Г. Кукеса. М. : Практическая медицина, 2014. 368 с.
35. Gould J.F., Smithers L.G., Makrides M. The effect of maternal omega-3 (n-3) LCPUFA supplementation during pregnancy on early childhood cognitive and visual development: a systematic review and meta-analysis of randomized controlled trials // Am. J. Clin. Nutr. 2013. Vol. 97, N 3. P. 531-544.
36. Middleton P., Gomersall J.C., Gould J.F., Shepherd E., Olsen S.F., Makrides M. Omega-3 fatty acid addition during pregnancy // Cochrane Database Syst. Rev. 2018. Vol. 11. CD003402. doi: 10.1002/14651858.CD003402.pub3
37. Mozaffarian D., Rimm E.B. Fish intake, contaminants, and human health: evaluating the risks and the benefits // JAMA. 2006. Vol. 296, N 15. P. 1885-1899.
38. US Food and Drug Administration, Center for Food Safety and Applied Nutrition. Agency Response Letter: GRAS Notice No. GRN 000080. 2001. URL: http://www.fda.gov/ohrms/dockets/dockets/95s0316/95s-0316-rpt0354-061-Ref-F-FDA-Response-Ltr-g80-vol273.pdf
39. Olsen S.F., Secher N.J. Randomized clinical trials of fish oil supplementation in high-risk pregnancies. Fish Oil Trials in Pregnancy (FO TIP) // BJOG. 2000. Vol. 107. Р. 382-395.
40. Salas Lorenzo I., Chisaguano Tonato A.M., de la Garza Puentes A. The effect of an infant formula supplemented with AA and DHA on fatty acid levels of infants with different FADS genotypes: The COGNIS Study // Nutrients. 2019. Vol. 11, N 3. P. 602. URL: https://doi.org/10.3390/nu11030602
41. Mozaffarian D., Wu J.H. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events // J. Am. Coll. Cardiol. 2011. Vol. 58, N 20. P. 20472067.
42. Abdelhamid A.S., Brown T.J., Brainard J.S., Biswas P., Thorpe G.C., Moore H.J. et al. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease // Cochrane Database Syst. Rev. 2018. Vol. 7. CD003177. doi: 10.1002/14651858.CD003177.pub3.
43. URL: https://www.cochrane.org/CD003177/VASC_omega-3-intake-cardiovascular-disease
44. American Heart Association. Frequently Asked Questions About Fish. URL: http://www.heart.org/HEARTORG/General/Frequently-Asked-Questions-About-Fish_UCM_306451_Article.jsp . (date of access April 25, 2014)
45. Mozaffarian D., Lemaitre R.N., King I.B. et al. Plasma phospholipid long-chain omega-3 fatty acids and total and cause-specific mortality in older adults: a cohort study // Ann. Intern. Med. 2013. Vol. 158, N 7. P. 515-525.
46. Zheng J., Huang T., Yu Y., Hu X., Yang B., Li D. Fish consumption and CHD mortality: an updated meta-analysis of seventeen cohort studies // Public Health Nutr. 2012. Vol. 15, N 4. P. 725-737.
47. Михин В.П., Швейнов А.И., Харченко А.В. Влияние омега-3 полиненасыщенных жирных кислот на аритмическую активность миокарда и показатели вариабельности сердечного ритма у пациентов с нестабильной стенокардией // Междунар. журн. сердца и сосудистых заболеваний. 2017. Т. 5, № 15. С. 46-50.
48. von Schacky C. Omega-3 index and cardiovascular health // Nutrients. 2014. Vol. 6, N 2. P. 799-814.
49. Flock M.R., Skulas-Ray A.C., Harris W.S., Etherton T.D., Fleming J.A., Kris-Etherton P.M. Determinants of erythrocyte omega-3 fatty acid content in response to fish oil supplementation: a dose-response randomized controlled trial // J. Am. Heart Assoc. 2013. Vol. 2, N 6. Article ID e000513.
50. Xun P., Qin B., Song Y. et al. Fish consumption and risk of stroke and its subtypes: accumulative evidence from a meta-analysis of prospective cohort studies // Eur. J. Clin. Nutr. 2012. Vol. 66, N 11. P. 1199-1207.
51. Chowdhury R., Stevens S., Gorman D. et al. Association between fish consumption, long chain omega 3 fatty acids, and risk of cerebrovascular disease: systematic review and meta-analysis // BMJ. 2012. Vol. 345. Article ID e6698.
52. Noaghiul S., Hibbeln J.R. Cross-national comparisons of seafood consumption and rates of bipolar disorders // Am. J. Psychiatry. 2003. Vol. 160, N 12. P. 2222-2227.
53. Locke C.A., Stoll A.L. Omega-3 fatty acids in major depression // World Rev. Nutr. Diet. 2001. Vol. 89. P. 173-185.
54. Кузенкова Л.М., Балканская С.В., Увакина Е.В. Место микронутриентов и полиненасыщенных жирных кислот в профилактике когнитивных нарушений у детей с синдромом дефицита внимания и гиперактивности. М., 2010.
55. Кузенкова Л.М., Намазова-Баранова Л.С., Балканская С.В., Увакина Е.В. Поливитамины и полиненасыщенные жирные кислоты в терапии гиперактивного расстройства с дефицитом внимания у детей // Педиатр. фармакол. 2009. № 3. С. 66-74.
References
1. Food and Nutrition Board, Institute of Medicine. Dietary fats: 7. total fat and fatty acids. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids. 8. Washington, DC: National Academies Press, 2002: 422-541.
2. Tyutyunnik V.L., Kan N.E., Lomov N.A., Klimantsev I.V. The 9. contribution of omega-3 to micronutrient support during pregnancy breast cancer. RMZH. Mat’ i ditya [RMJ. Mother and Child]. 2017; (15): 1087-91. (in Russian)
3. Shih E.V., Makhova A.A. The endemicity of the territory in terms of micronutrient deficiencies as a criterion for the formation of the basic vitamin-mineral complex for the peri-conceptual period. Akusherstvo i ginekologiya [Obstetrics and Gynecology]. 2018; (10): 25-32. (in Russian)
4. Caron J.P., Gandy J.C., Brown J.L., Sordillo L.M. Omega-3 fatty acids and docosahexaenoic acid oxymetabolites modulate the inflammatory response of equine recombinant interleukin1p-stim-ulated equine synoviocytes. Prostaglandins Other Lipid Mediat. 2019; 142: 1-8. doi: 10.1016/j.prostaglandins.2019.02.007
5. Gavrisyuk V.K. The use of omega-3 polyunsaturated fatty acids in medicine. Ukr. pulmon. journal. 2001; (3): 5-10. (in Russian)
6. Stark K.D., Van Elswyk M.E., Higgins M.R., Weatherford C.A., Salem N. Jr. Global survey of the omega-3 fatty acids, docosa-hexaenoic acid and eicosapentaenoic acid in the blood stream of healthy adults. Progr Lipid Res. 2016; 63: 132-52.
7. The diet of the population. 2013: Statistical compendium. Rosstat. Moscow: Statistika v Rossii, 2016: 220 p. (in Russian)
8. Calder P.C. Docosahexaenoic acid. Ann Nutr Metab. 2016; 69 (1): 7-21.
9. Carlson S.J., O’Loughlin A.A., Anez-Bustillos L., et al. A diet with docosahexaenoic and arachidonic acids as the sole source of polyunsaturated fatty acids is sufficient to support visual, cognitive, motor, and social development in mice. Front Neurosci. 2019; 13: 72. doi: 10.3389/fnins.2019.00072
10. Jeffrey B.G., Weisingerb H.S., Neuringer M., Mitcheli D.C. The role of docosahexaenoic acid in retinal function. Lipids. 2001; 36 (9): 859-71.
11. SanGiovanni J.P., Chew E.Y. The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Retin Eye Res. 2005; 24 (1): 87-138.
12. Dyall S.C. Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA. Front Aging Neurosci. 2015; 7: 52. doi: 10.3389/fnagi.2015.00052
13. Zemdegs J., Rainer Q., Grossmann C.P., et al. Anxiolytic- and antidepressant-like effects of fish oil-enriched diet in brain-derived neurotrophic factor deficient mice. Front Neurosci. 2018; 12: 974. doi: 10.3389/fnins.2018.00974
14. Martins B.P., Bandarra N.M., Figueiredo-Braga M. The role of marine omega-3 in human neurodevelopment, including Autism Spectrum Disorders and Attention-Deficit/Hyperactivity Disorder - a review. Crit Rev. Food Sci Nutr. 2019; Mar 18: 1-16. doi: 10.1080/10408398.2019.1573800
15. Ishihara T., Yoshida M., Arita M. Omega-3 fatty acid-derived mediators that control inflammation and tissue homeostasis. Int Immunol. 2019. pii: dxz001. doi: 10.1093/intimm/dxz001
16. Davidson M.H. Omega-3 fatty acids: new insights into the pharmacology and biology of docosahexaenoic acid, docosapentaenoic acid, and eicosapentaenoic acid. Curr Opin Lipidol. 2013; 24 (6): 467-74.
17. Jump D.B., Tripathy S., Depner C.M. Fatty acid-regulated transcription factors in the liver. Annu Rev Nutr. 2013; 33: 249-69.
18. Cho H.P., Nakamura M., Clarke S.D. Cloning, expression, and fatty acid regulation of the human delta-5 desaturase. J Biol Chem. 1999; 274 (52): 37 335-9.
19. Burdge G.C., Wootton S.A. Conversion of a-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. Br J Nutr. 2002; 88 (4): 411-20.
20. Burdge G.C., Jones A.E., Wootton S.A. Eicosapentaenoic and doc-osapentaenoic acids are the principal products of a-linolenic acid metabolism in young men. Br J Nutr. 2002; 88 (4): 355-64.
21. Conquer J.A., Holub B.J. Dietary docosahexaenoic acid as a source of eicosapentaenoic acid in vegetarians and omnivores. Lipids. 1997; 32 (3): 341-5.
22. Flock M.R., Harris W.S., Kris-Etherton P.M. Long-chain omega-3 fatty acids: time to establish a dietary reference intake. Nutr Rev. 2013; 71 (10): 692-707.
23. Gromova O.A., Torshin I.Yu., Egorova E.Yu. Omega-3 polyunsaturated fatty acids and cognitive development of children. Voprosy sovremennoy pediatrii [Problems of Modern Pediatrics]. 2011; 10 (1): 44-9. (in Russian)
24. Makarova S.G., Vishneva E.A. Modern ideas about the effect of long-chain polyunsaturated fatty acids on the development of the nervous system in children. Voprosy sovremennoy pediatrii [Problems of Modern Pediatrics]. 2015; 14 (1): 55-6. (in Russian)
25. Ulven S.M., Kirkhus B., Lamglait A., et al. Metabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteers. Lipids. 2011; 46 (1): 37-46.
26. Hendler S.S., Rorvik D.R. (eds). PDR for nutritional supplements. Montvale: Medical Economics Company, 2001: 797 p.
27. URL: http://www.mstu.edu.ru/science/actions/conferences/files/ecol2015-10.pdf
28. URL: http://www.vniro.ru/files/publish/boeva_tehnologia_jirov.pdf
29. Kirpal S. Sidhu Health benefits and potential risks related to consumption of fish or fish oil. Regul Toxicol Pharmacol. 2003; 38: 336-44.
30. Vaskovsky V.E., Gorbach T.F., Esipov A.V. Preparations of Omega-3 fatty acids and their use in medicine. Tikhookeanskiy meditsinskiy zhurnal [Pacific Medical Journal]. 2010; (2): 15-9. (in Russian)
31. Makarova S.G., Vishneva E.A. Long-chain polyunsaturated fatty acids classes -3 and -6 as an essential nutrient in different periods of childhood. Pediatricheskaya farmakologiya [Pediatric Pharmacology]. 2013; 10 (4): 80-8. (in Russian)
32. Burdge G.C., Calder P.C. Conversion of a-linolenic acid to longer-chain polyunsaturated fatty acids in human adult. Reprod Nutr Dev. 2005; 45: 581-97.
33. Pilz S., Zittermann A., Trummer C., et al. Vitamin D testing and treatment: a narrative review of current evidence. Endocr Connect. 2019; 8 (2): R27-43.
34. Shikh E.V., Makhova A.A. Vitamins in clinical practice. Edited by W.G. Kukes. Moscow: Prakticheskaya Meditsina, 2014: 368 p. (in Russian)
35. Gould J.F., Smithers L.G., Makrides M. The effect of maternal omega-3 (n-3) LCPUFA supplementation during pregnancy on early childhood cognitive and visual development: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr. 2013; 97 (3): 531-44.
36. Middleton P., Gomersall J.C., Gould J.F., Shepherd E., Olsen S.F., Makrides M. Omega-3 fatty acid addition during pregnancy. Cochrane Database Syst Rev. 2018; 11: CD003402. doi: 10.1002/14651858.CD003402.pub3
37. Mozaffarian D., Rimm E.B. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA. 2006; 296 (15): 1885-99.
38. US Food and Drug Administration, Center for Food Safety and Applied Nutrition. Agency Response Letter: GRAS Notice No. GRN 000080. 2001. URL: http://www.fda.gov/ohrms/dockets/dockets/95s0316/95s-0316-rpt0354-061-Ref-F-FDA-Response-Ltr-g80-vol273.pdf
39. Olsen S.F., Secher N.J. Randomized clinical trials of fish oil supplementation in high-risk pregnancies. Fish Oil Trials in Pregnancy (FO TIP). BJOG. 2000; 107: 382-95.
40. Salas Lorenzo I., Chisaguano Tonato A.M., de la Garza Puentes A. The effect of an infant formula supplemented with AA and DHA on fatty acid levels of infants with different FADS genotypes: The COGNIS Study. Nutrients. 2019; 11 (3): 602. URL: https://doi.org/10.3390/nu11030602
41. Mozaffarian D., Wu J.H. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol. 2011; 58 (20): 2047-67.
42. Abdelhamid A.S., Brown T.J., Brainard J.S., Biswas P., Thorpe G.C., Moore H.J., et al. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2018; 7: CD003177. doi: 10.1002/14651858.CD003177.pub3
43. URL: https://www.cochrane.org/CD003177/VASC_omega-3-intake-cardiovascular-disease
44. American Heart Association. Frequently asked questions about fish. URL: http://www.heart.org/HEARTORG/General/Frequently-Asked-Questions-About-Fish_UCM_306451_Article.jsp (date of access April 25, 2014)
45. Mozaffarian D., Lemaitre R.N., King I.B., et al. Plasma phospholipid long-chain omega-3 fatty acids and total and cause-specific mortality in older adults: a cohort study. Ann Intern Med. 2013; 158 (7): 515-25.
46. Zheng J., Huang T., Yu Y., Hu X., Yang B., Li D. Fish consumption and CHD mortality: an updated meta-analysis of seventeen cohort studies. Public Health Nutr. 2012; 15 (4): 725-37.
47. Mikhin V.P., Shveynov A.I., Kharchenko A.V. The effect of omega-3 polyunsaturated fatty acids on the arrhythmic activity of the myocardium and on the indices of heart rate variability in patients with unstable angina. Mezhdunarodniy zhurnal sedtsa i sosudistykh zabolevaniy [International Journal of Heart and Vascular Diseases]. 2017; 5 (15): 46-50. (in Russian)
48. von Schacky C. Omega-3 index and cardiovascular health. Nutrients. 2014; 6 (2): 799-814.
49. Flock M.R., Skulas-Ray A.C., Harris W.S., Etherton T.D., Fleming J.A., Kris-Etherton P.M. Determinants of erythrocyte omega-3 fatty acid content in response to fish oil supplementation: a dose-response randomized controlled trial. J Am Heart Assoc. 2013; 2 (6): e000513.
50. Xun P., Qin B., Song Y., et al. Fish consumption and risk of stroke and its subtypes: accumulative evidence from a meta-analysis of prospective cohort studies. Eur J Clin Nutr. 2012; 66 (11): 1199-207.
51. Chowdhury R., Stevens S., Gorman D., et al. Association between fish consumption, long chain omega 3 fatty acids, and risk of cerebrovascular disease: systematic review and meta-analysis. BMJ. 2012; 345: e6698.
52. Noaghiul S., Hibbeln J.R. Cross-national comparisons of seafood consumption and rates of bipolar disorders. Am J Psychiatry. 2003; 160 (12): 2222-7.
53. Locke C.A., Stoll A.L. Omega-3 fatty acids in major depression. World Rev Nutr Diet. 2001; 89: 173-85.
54. Kuzenkova L.M., Balkanskaya S.V., Uvakina Ye.V. The place of micronutrients and polyunsaturated fatty acids in the prevention of cognitive impairment in children with attention deficit hyperactivity disorder. Moscow, 2010. (in Russian)
55. Kuzenkova L.M., Namazova-Baranova L.S., Balkanskaya S.V., Uvakina E.V. Polyvitamins and polyunsaturated fatty acids in the treatment of attention-deficit hyperactive disorder in children. Pediatricheskaya farmakologiya [Pediatric Pharmacology]. 2009; (3): 66-74. (in Russian)